Celularity Inc.
CELU
$1.66
-$0.01-0.60%
NASDAQ
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -23.24% | -17.51% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -23.24% | -17.51% | |||
| Cost of Revenue | 82.90% | 29.45% | |||
| Gross Profit | -45.80% | -23.41% | |||
| SG&A Expenses | -20.48% | 13.39% | |||
| Depreciation & Amortization | -17.76% | -16.48% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.56% | 1.04% | |||
| Operating Income | -13.29% | -37.95% | |||
| Income Before Tax | -148.12% | 70.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -148.12% | 70.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -148.12% | 70.53% | |||
| EBIT | -13.29% | -37.95% | |||
| EBITDA | -17.78% | -56.69% | |||
| EPS Basic | -146.72% | 71.08% | |||
| Normalized Basic EPS | -149.21% | 65.35% | |||
| EPS Diluted | -146.72% | 71.08% | |||
| Normalized Diluted EPS | -149.21% | 65.35% | |||
| Average Basic Shares Outstanding | 0.58% | 1.91% | |||
| Average Diluted Shares Outstanding | 0.58% | 1.91% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||